Form 4 Filing for Jennifer E. Cook

Jennifer E. Cook, a director at BridgeBio Pharma, Inc., reported several transactions involving the company's Common Stock. On June 22, 2026, she acquired 3,990 restricted stock units (RSUs) with a post-transaction share count of 10,579. These RSUs vest on June 22, 2027. On June 23, 2026, she disposed of 2,196 shares at a price of $68.57 per share, reducing her holdings to 8,383 shares. On June 24, 2026, she acquired 20,000 shares at $8.45 and 17,167 shares at $16.75, increasing her post-transaction holdings to 45,550 shares. Concurrently, she disposed of 37,167 shares at $70.00 per share, resulting in a final post-transaction share count of 8,383. Additionally, Cook was granted stock options, with some transactions involving the exercise and disposal of these options as part of a Rule 10b5-1 sales plan. Notably, the options acquired on June 22, 2026, for 5,277 shares at a $0.00 price, vest on June 22, 2027. Other option transactions on June 24, 2026, involved the disposal of 20,000 and 17,167 shares at $0.00 prices, with resulting post-transaction holdings of 19,000 and 17,167 shares, respectively. The conversion or exercise prices for these options were $8.45 and $16.75.